According to the depicted illustration (Fig. 6a, e), after the establishment of in situ BC and PC, IgG control, anti-CD24 mAb, SAMIs and PAC-SABIs were administered every other day for a total of 4 doses. This evidence concerns the gene CD24 and breast cancer.